- Home
- NVS vs ABT Comparison
NVS vs ABT Comparison
Compare NVS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- ABT
- Stock Information
- Founded
- NVS 1895
- ABT 1888
- Country
- NVS Switzerland
- ABT United States
- Employees
- NVS N/A
- ABT N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- ABT Medical/Dental Instruments
- Sector
- NVS Health Care
- ABT Health Care
- Exchange
- NVS Nasdaq
- ABT Nasdaq
- Market Cap
- NVS 242.8B
- ABT 233.7B
- IPO Year
- NVS 1991
- ABT N/A
- Fundamental
- Price
- NVS $126.51
- ABT $132.69
- Analyst Decision
- NVS Hold
- ABT Strong Buy
- Analyst Count
- NVS 6
- ABT 19
- Target Price
- NVS $123.67
- ABT $142.79
- AVG Volume (30 Days)
- NVS 1.3M
- ABT 5.3M
- Earning Date
- NVS 10-28-2025
- ABT 10-15-2025
- Dividend Yield
- NVS 2.05%
- ABT 1.78%
- EPS Growth
- NVS N/A
- ABT 151.50
- EPS
- NVS 6.85
- ABT 7.97
- Revenue
- NVS $55,186,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- NVS $9.01
- ABT $7.60
- Revenue Next Year
- NVS $2.49
- ABT $7.84
- P/E Ratio
- NVS $17.93
- ABT $16.64
- Revenue Growth
- NVS 12.95
- ABT 5.85
- 52 Week Low
- NVS $96.06
- ABT $110.86
- 52 Week High
- NVS $128.03
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- NVS 63.71
- ABT 53.33
- Support Level
- NVS $125.82
- ABT $130.14
- Resistance Level
- NVS $127.07
- ABT $133.62
- Average True Range (ATR)
- NVS 1.20
- ABT 1.91
- MACD
- NVS 0.34
- ABT 0.07
- Stochastic Oscillator
- NVS 84.31
- ABT 62.77
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.